Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verastem

5.60
-0.2800-4.76%
Post-market: 5.770.1700+3.04%19:45 EDT
Volume:1.30M
Turnover:7.37M
Market Cap:307.72M
PE:-1.60
High:5.84
Open:5.78
Low:5.58
Close:5.88
Loading ...

FDA Grants Accelerated Approval to Combination of Avutometinib and Defactinib for Kras-Mutated Recurrent Low-Grade Serous Ovarian Cancer

THOMSON REUTERS
·
09 May

Verastem Stock Trading Halted on Nasdaq, Pending Material News Release

MT Newswires Live
·
08 May

Verastem Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
05 May

Verastem participates in a conference call with Cantor Fitzgerald

TIPRANKS
·
01 May

Verastem Inc. to Present at Upcoming H.C. Wainwright BioConnect Investor Conference

Reuters
·
01 May

Verastem Oncology to Present at Upcoming Investor Conferences

Business Wire
·
01 May

Verastem Shares Rise After Agreement to Sell Securities Worth Roughly $75 Million

MT Newswires Live
·
25 Apr

Verastem Announces $75M Private Placement Agreement

TIPRANKS
·
25 Apr

Verastem Oncology Announces $75 Million Private Placement

THOMSON REUTERS
·
25 Apr

Verastem Inc - Private Placement Expected to Close on April 28, 2025

THOMSON REUTERS
·
25 Apr

Verastem Inc - to Sell $24 Million in Common Stock at $7.00 per Share

THOMSON REUTERS
·
25 Apr

BRIEF-Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors

Reuters
·
24 Apr

Verastem announces U.S. IND clearance of VS-7375

TIPRANKS
·
24 Apr

Verastem Inc - Phase 1/2a Trial in U.S. to Start Mid-2025

THOMSON REUTERS
·
24 Apr

Verastem Oncology Announces U.S. Ind Clearance of VS-7375, Oral Kras G12d (on/off) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors

THOMSON REUTERS
·
24 Apr

Top Cancer Stocks to Buy to Boost Your Portfolio's Health

Zacks
·
16 Apr

Jefferies Initiates Verastem at Buy With $15 Price Target

MT Newswires Live
·
10 Apr

Verastem Initiated at Buy by Jefferies

Dow Jones
·
10 Apr

Verastem initiated with a Buy at Jefferies

TIPRANKS
·
10 Apr

U.S. RESEARCH ROUNDUP- Carnival, JLL, Microsoft

Reuters
·
10 Apr